Addiction News and Research

RSS

Scientists discover and block pathway responsible for link between stress, anxiety and depression

Scientists at The University of Western Ontario have discovered the biological link between stress, anxiety and depression. By identifying the connecting mechanism in the brain, this high impact research led by Stephen Ferguson of Robarts Research Institute shows exactly how stress and anxiety could lead to depression.

12 Apr 2010

Catalyst Pharmaceutical Partners' vigabatrin data to be presented at 41st ASAM conference

Catalyst Pharmaceutical Partners, Inc. today announced that on Friday April 16th, Eugene C. Somoza, MD, PhD, University of Cincinnati College of Medicine and VA Medical Center, Cincinnati, OH will present a paper he authored along with Charles Gorodetzky, MD, PhD, Douglas Winship and Peggy Somoza, entitled: "A Multi-Site, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Vigabatrin (VGB) for Treating Cocaine Dependence"

9 Apr 2010

Liver transplant loan repayment expected says WA Premier

Claire Murray, 24 died last week in a Singapore hospital following complications related to her second liver transplant. Her first tax-payer funded transplanted liver was damaged due to her relapsing into heroin addiction.

7 Apr 2010

Achievements of AFC, Abbott to be highlighted at AFC's 25th Anniversary Gala

Two events occurred in 1985 that proved pivotal in the local and national fight against AIDS: the founding of the AIDS Foundation of Chicago and the development of the first-ever diagnostic test licensed to identify HIV in the blood by Abbott.

6 Apr 2010

SRI director on importance of seeking treatment for sex addiction

Following rumours that Jesse James has checked into rehab for sex addiction, Robert Weiss, LCSW, CSAT-S, founding director of the Sexual Recovery Institute, today issued the following statement to explain how simple pleasure oriented behaviours can evolve into addiction and the importance of seeking treatment.

3 Apr 2010

Clinical utility and pharmacological action of MN-166 in treatment of MS

MediciNova, Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported that this week's issue of Neurology includes two articles related to the potential clinical utility and unique pharmacological action of MN-166 in treating multiple sclerosis (MS).

3 Apr 2010

Growing problem of prescription drug abuse

Prescription painkiller abuse is a rapidly growing and widespread problem, recently coming into full view due to high profile stories and tragic celebrity deaths.

3 Apr 2010

Tel Aviv University researcher finds link between cigarette smoking and IQ

"Only dopes use dope," goes the memorable warning about drugs. Now a Tel Aviv University researcher cautions that the same goes for cigarettes.

2 Apr 2010

An inability to switch off - workers stressed by technology

The much-touted "work/life balance" has been found to be riddled with paradox with new research showing work-related email invading workers' homes and leisure spaces, causing stress, anxiety, an inability to switch off, as well as potential damage to family relationships.

1 Apr 2010

Young mother dies of post-liver transplant complications in Singapore

Claire Murray, a 25 year old woman from Perth, suffered from a liver failure due to drug addition. She underwent a controversial second live liver transplant where a part of her aunt’s liver was given to her two weeks ago. She has reportedly succumbed to her condition and died just before 12:00pm (AWST) from complications in Singapore.

1 Apr 2010

Catalyst Pharmaceutical Partners reports net loss of $7.24M for fourth-quarter 2009

Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.

1 Apr 2010

Radio show on ways to reduce sugar intake and live healthier

Monday, April 5th at 7pm EDT (4pm PDT) on the Telonauts Hour Radio Show Dr. Jacob Teitelbaum MD, author of Beat Sugar Addiction Now, will join longevity expert Dr. Dave Woynarowski MD and fitness pioneer Greta Blackburn, both of Telonauts.com, to discuss ways people can reduce their sugar intakes and live healthier, less sugar-addicted lives.

1 Apr 2010

CAMH embarks on next phase of landmark redevelopment project

The Centre for Addiction and Mental Health is making history. On April 6, CAMH is breaking ground on the next phase of its landmark redevelopment project, transforming the site of what was originally the 1850 Provincial Lunatic Asylum into a modern, welcoming 'urban village' in the heart of Queen Street West. Nothing quite like this has ever been done before.

31 Mar 2010

Nation's emergency physicians warn parents about dangers of prescription drug abuse

The nation's emergency physicians are issuing a strong warning to parents about the dangers of prescription drug abuse, which are now the second most abused drugs, after marijuana. Nearly three-quarters of a million people (741,425) needed emergency care in 2006 because of prescription drug abuse.

31 Mar 2010

New clues may help explain why some people are more susceptible to stress than others

UT Southwestern Medical Center researchers have found new clues that might help explain why some people are more susceptible to stress than others.

31 Mar 2010

Titan Pharmaceuticals commences Phase 3 study of Probuphine for opioid addiction

Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and placebo (50 patients).

31 Mar 2010

Call to ban Miaow-Miaow - Mephedrone

Mephedrone also known as “m-cat” or “miaow-miaow” is a synthetic stimulant drug that has effects similar to amphetamines and ecstasy. Mephedrone use has spread fast in UK since it emerged at a pop festival on the Isle of Wight in July last year.

30 Mar 2010

Unrestricted availability of food can trigger overconsumption and obesity

Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health.

29 Mar 2010

Addiction to high calorie fat rich food: likened to cocaine and heroin addiction

In a new research our worst fears are confirmed – fatty, fried and fattening foods are addictive. The addiction with these delicious ‘yummies’ may be as potent as that with cocaine or heroin. The study was conducted on experimental animals, rats in this case. When fed with fatty foods in great quantities these rats showed a compulsive need to eat.

29 Mar 2010

Study provides new clues to obesity epidemic

In a newly published study, scientists from The Scripps Research Institute have shown for the first time that the same molecular mechanisms that drive people into drug addiction are behind the compulsion to overeat, pushing people into obesity.

29 Mar 2010